查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1802938

VR 暴露疗法市场预测（至 2032 年）：按组件、疗法类型、技术、应用、最终用户和地区进行的全球分析

VR Exposure Therapy Market Forecasts to 2032 - Global Analysis By Component, Therapy Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球 VR 暴露疗法市场预计在 2025 年价值 4.0766 亿美元，到 2032 年将达到 21.4849 亿美元，预测期内的复合年增长率为 26.8%。

虚拟实境暴露疗法 (VRET) 是一种心理疗法，它利用身临其境型虚拟环境，帮助患者在安全可控的环境中面对和管理恐惧、焦虑和创伤记忆。与依赖想像和真实生活情境的传统暴露疗法不同，VRET 允许治疗师以高度的灵活性和真实感重现特定场景，例如飞行、公开演讲或战斗环境。 VRET 对恐惧症、创伤后压力症候群 (PTSD) 和社交焦虑等疾病尤其有效。

《虚拟实境前沿》（Frontiers in Virtual Reality）发表的一项研究发现，一次30分钟的VR过度暴露疗法就能显着降低青少年的公开演讲焦虑。参与者报告称，他们的自信心和乐趣都有所提升，这证明了身临其境型环境在治疗社交焦虑症方面的潜力。

对非侵入性疗法的需求日益增长

在全球范围内，精神疾病的发生率不断上升，推动了对创造性、非侵入性和有效治疗方法的需求。 VR暴露疗法透过提供安全、沉浸式的环境来满足这项需求，患者可以在密切监督下逐渐面对自己的创伤和恐惧。与主要依赖想像力和有副作用的药物的传统谈话疗法相比，虚拟实境(VR)提供了一种积极的治疗过程，并且疗效可量化。 VR的互动性可以提高患者的参与度，尤其适合年轻人和不愿尝试传统疗法的人。

初始成本高且定价有限

软体和设备的高昂初始成本是限制 VR 暴露疗法市场的主要因素之一。先进的VR头戴装置、动作感测器和专门的治疗软体成本高昂，这给独立治疗师、小型诊所和新兴医疗系统采用这些疗法带来了困难。除了硬体之外，其他成本还包括系统维护、从业人员培训和治疗模组客製化。此外，许多保险公司仍然不愿意承担基于 VR 的干预费用，因此只能由患者和医疗服务提供者自行承担费用。儘管 VR 疗法已被证明有效，但这些经济差距减缓了它的普及，并限制了它的广泛应用，尤其是在医疗预算有限的地区。

职场心理健康和企业健康的成长

VR暴露疗法为企业健康计画提供了巨大的潜力，尤其是在职场压力、倦怠和焦虑日益加剧的当下。企业正在加大对员工心理健康专案的投入，以提高工作满意度、员工留任率和工作效率。 VR解决方案可以帮助员工管理压力、提高专注力，并克服公开演讲等表现焦虑问题。这些解决方案可以远端交付，也可以整合到企业健康中心。与传统咨询相比，游戏化的虚拟实境疗程可以提高健康项目的参与度。随着企业转向主动心理健康管理，虚拟实境疗法提供了一种新颖且可扩展的解决方案，使服务提供者能够利用盈利的企业医疗保健和人力资源市场。

来自替代医学的竞争

儘管VR暴露疗法具有独特的优势，但它仍面临着来自新兴和传统数位解决方案的激烈竞争。由于成熟的报销途径和强有力的临床证据，药物疗法、认知行为疗法 (CBT) 和传统暴露疗法仍然被广泛使用。扩增实境疗法、行动心理健康应用程式和人工智慧主导的认知介入等替代数位工具也越来越受欢迎。这些替代方案通常比VR更便宜、更容易获得，并且所需的设备更少。此外，除非VR解决方案能够以更好的疗效和扩充性脱颖而出，否则其长期市场渗透率可能会受到限制。

COVID-19的影响：

新冠疫情 (COVID-19) 疫情对 VR 暴露疗法市场造成了重大衝击，既带来了机会，也带来了挑战。由于封锁和保持社交距离措施限制了面对面的治疗，对远距和数位化心理健康解决方案（包括基于 VR 的干预措施）的需求增加。随着患者和临床医生转向身临其境型VR 平台，以便在家中安全地继续进行暴露疗法，远端医疗整合 VR 解决方案的使用也随之增加。同时，供应链中断和硬体取得受限暂时限制了其应用。疫情凸显了远距、可扩展且技术先进的治疗方法的重要性，使 VR 暴露疗法成为现代心理健康护理的关键工具。

预计VR头戴装置市场将成为预测期内最大的市场

预计VR头戴装置领域将在预测期内占据最大的市场占有率。这些头戴装置对于提供3D身临其境型治疗体验至关重要，使其成为治疗焦虑症、恐惧症和创伤后压力症候群 (PTSD) 的关键组成部分。由于虚拟实境技术的进步，独立式、无线式和支援智慧型手机的头戴装置的开发提高了可近性和使用者舒适度。此外，由于 VR 暴露疗法价格实惠且易于使用，该设备在临床环境中的广泛使用推动了其扩展。随着对尖端心理健康治疗的需求不断增长， VR头戴装置预计将保持其市场领先地位。

预计远端医疗平台和数位治疗提供者部门将在预测期内实现最高的复合年增长率。

远端医疗平台和数位疗法提供者领域预计将在预测期内呈现最高成长率。对便捷的远距心理健康介入服务的需求日益增长，尤其是在医疗资源匮乏和农村地区，这推动了这一增长。远端医疗平台消除了等待时间和出行限制等障碍，使患者能够在舒适的家中参与基于虚拟实境的暴露疗法。数位疗法提供者透过提供个人化、基于研究的治疗内容，并频繁整合人工智慧技术进行即时回馈和自适应治疗方案，从而改善了这一体验。

比最大的地区

预计北美将在预测期内占据最大的市场占有率，主要由加拿大和美国推动。该地区受益于对数位疗法和心理健康研究的大量投资、数位健康技术的广泛使用以及先进的医疗保健基础设施。焦虑症、创伤后压力症候群和恐惧症的盛行率不断上升，以及人们对心理健康问题认识的不断提高，正在加速诊所、医院和私人诊所采用基于 VR 的暴露疗法。此外，北美作为全球最盈利、成长最快的 VR 暴露疗法市场的主导地位可以归因于强有力的政府倡议、优惠的报销政策以及顶级 VR 技术提供者的存在。

复合年增长率最高的地区：

预计亚太地区 (APAC) 将在预测期内实现最高的复合年增长率。这一增长主要源于医疗保健的快速数位化、心理健康意识的不断提升以及尖端治疗技术的日益普及。中国、日本、印度和韩国等国家正在增加对基于虚拟实境 (VR) 的心理健康解决方案的投资，同时对远端保健和医疗基础设施的投资也在增加。此外，庞大的患者群体、日益增长的压力和焦虑水平以及鼓励数位医疗创新的政府计画也推动了这个市场的发展。

提供免费客製化：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球VR暴露疗法市场（按组件）

  • VR头戴装置
  • VR软体和模组
  • VR工作站
  • VR耳机
  • VR位置追踪器/感测器
  • 生物回馈疗法监测器
  • 其他组件

6. 全球VR暴露疗法市场（依治疗类型）

  • 创伤后压力症候群（PTSD）
  • 恐惧症
  • 焦虑症
  • 强迫性精神官能症（OCD）
  • 成瘾和药物滥用
  • 忧郁症和情绪障碍
  • 其他治疗类型

7. 全球VR暴露疗法市场（按技术）

  • 完全身临其境型现实
  • 半身临其境型VR
  • 非身临其境型VR
  • AI增强型VR
  • 触觉整合虚拟现实

8. 全球VR暴露疗法市场（按应用）

  • 管理精神障碍和成瘾
  • 治疗儿童焦虑和恐惧症
  • 教育和医疗培训
  • 远端医疗和远端医疗整合
  • 其他用途

9. 全球VR暴露疗法市场（按最终用户）

  • 医院和诊所
  • 心理健康中心
  • 学术和研究机构
  • 私人治疗实践
  • 政府和国防机构
  • 远端医疗平台和数位治疗提供者
  • 其他最终用户

第 10 章全球 VR 暴露疗法市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Google
  • Accelerated Care Plus Corporation
  • Microsoft
  • ImmersiveTouch Inc
  • Oculus VR Inc
  • Atheer
  • Mindmaze Inc
  • BehaVR Inc
  • Limbix Inc.
  • AppliedVR Inc
  • Samsung Electronics
  • Virtually Better, Inc.
  • Echopixel Inc
  • XRHealth Inc
  • Truevision Inc
  • Vivid Vision
  • Oxford VR Inc
Product Code: SMRC30464

According to Stratistics MRC, the Global VR Exposure Therapy Market is accounted for $407.66 million in 2025 and is expected to reach $2148.49 million by 2032 growing at a CAGR of 26.8% during the forecast period. Virtual Reality Exposure Therapy (VRET) is a type of psychological treatment that helps people face and control their fears, anxieties, or traumatic memories in a safe and controlled environment by using immersive virtual environments. In contrast to conventional exposure therapy, which depends on imagination or real-world circumstances, VRET enables therapists to replicate particular scenarios-like flying, public speaking, or combat environments-with a high level of flexibility and realism. It is particularly useful for disorders like phobias, post-traumatic stress disorder (PTSD), and social anxiety because it allows patients to gradually become less sensitive to their triggers while still feeling safe.

According to a study published in Frontiers in Virtual Reality, a single 30-minute session of VR-based overexposure therapy significantly reduced public speaking anxiety among adolescents. Participants reported improved confidence and enjoyment, demonstrating the potential of immersive environments to treat social anxiety disorders.

Market Dynamics:

Driver:

Growing need for engaging, non-invasive therapies

Globally, the prevalence of mental health disorders is rising, which has increased demand for creative, non-invasive, and effective treatment approaches. This need is met by VR exposure therapy, which provides safe, immersive settings in which patients can progressively face traumas or fears while being closely monitored. Virtual reality (VR) offers an active therapeutic process with quantifiable progress, in contrast to traditional talk therapy that mainly relies on imagination or medications that may have negative side effects. It is particularly useful for younger populations or those who are hesitant to try conventional therapy because of its interactive nature, which guarantees higher patient engagement.

Restraint:

Expensive initial outlay and restricted affordability

The high initial cost of software and equipment is one of the main factors limiting the market for VR exposure therapy. Adoption is challenging for independent therapists, small clinics, and emerging healthcare systems due to the high cost of advanced VR headsets, motion sensors, and specialized therapeutic software. In addition to hardware, other expenses include maintaining systems, training practitioners, and customizing therapy modules. Moreover, the cost of VR-based interventions is still borne by patients or providers because many insurers are still reluctant to pay for them. Even though VR therapy has been shown to be effective, its democratization is being slowed down by this affordability gap, which restricts its widespread adoption, particularly in areas with low healthcare budgets.

Opportunity:

Growth in workplace mental health and corporate wellness

VR exposure therapy has a lot of potential for corporate wellness programs, especially since workplace stress, burnout, and anxiety are on the rise. Businesses are spending more money on employee mental health programs in an effort to increase job satisfaction, retention, and productivity. VR solutions can help employees manage stress, increase focus, and get over performance anxiety issues like public speaking. They can be offered remotely or integrated into corporate wellness centers. Compared to traditional counseling, gamified virtual reality sessions enhance the engagement of wellness programs. As businesses move toward proactive mental health management, virtual reality therapy presents a novel, scalable solution that puts providers in a position to take advantage of the profitable corporate healthcare and human resources markets.

Threat:

Competition from alternative medical practices

Even though VR exposure therapy has special advantages, it is fiercely competitive with both new and traditional digital solutions. Medication, cognitive behavioral therapy (CBT), and traditional exposure therapy are still commonly used because they have established reimbursement pathways and strong clinical evidence. Alternative digital tools are also becoming more popular, including augmented reality therapies, mobile mental health apps, and AI-driven cognitive interventions. Comparing these alternatives to VR, they are frequently less expensive, more accessible, and require less equipment. Additionally, long-term market penetration may be limited if VR solutions are unable to set themselves apart with better results and scalability, as they run the risk of losing market share to these rival therapeutic modalities.

Covid-19 Impact:

The market for VR exposure therapy was significantly impacted by the COVID-19 pandemic, which presented both opportunities and difficulties. Demand for remote and digital mental health solutions, such as VR-based interventions, increased as a result of lockdowns and social distancing measures that limited in-person therapy sessions. The use of telehealth-integrated VR solutions has increased as patients and clinicians have resorted to immersive VR platforms to safely continue exposure therapy from home. At the same time, deployment was momentarily limited by supply chain interruptions and restricted hardware access. All things considered, the pandemic demonstrated the importance of remote, scalable, and technologically advanced therapeutic approaches, establishing VR exposure therapy as a vital instrument in contemporary mental health care.

The VR headset segment is expected to be the largest during the forecast period

The VR headset segment is expected to account for the largest market share during the forecast period. These headsets are essential for providing three-dimensional, immersive therapeutic experiences, which makes them a key component of treatments for anxiety disorders, phobias, and PTSD. The development of standalone, wireless, and smartphone-compatible headsets has improved accessibility and user comfort as a result of advancements in virtual reality technology. Moreover, the expansion of VR exposure therapy has been fueled by the devices' widespread use in clinical settings, which can be attributed to their affordability and ease of use. VR headsets are anticipated to maintain their market-leading position as the need for cutting-edge mental health treatments increases.

The telehealth platforms & digital therapeutics providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the telehealth platforms & digital therapeutics providers segment is predicted to witness the highest growth rate. The growing need for easily accessible, remote mental health interventions-particularly in underprivileged or rural areas-is what is driving this expansion. By removing obstacles like wait times and travel restrictions, telehealth platforms allow patients to participate in VR-based exposure therapy from the convenience of their homes. By providing individualized, research-based therapeutic content and frequently incorporating AI for real-time feedback and adaptive treatment plans, digital therapeutics providers improve these experiences.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, primarily propelled by Canada and the United States. The area gains from substantial investments in digital therapeutics and mental health research, as well as from the extensive use of digital health technologies and sophisticated healthcare infrastructure. The growing prevalence of anxiety, PTSD, and phobias, along with increased awareness of mental health issues, has sped up the adoption of VR-based exposure therapy in clinics, hospitals, and private therapy settings. Furthermore, North America's dominant position as the most profitable and quickly developing market for VR exposure therapy worldwide is a result of robust government initiatives, advantageous reimbursement policies, and the presence of top VR technology providers.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific (APAC) region is anticipated to exhibit the highest CAGR. This expansion is being propelled by the quick digitization of healthcare, rising mental health awareness, and expanding use of cutting-edge therapeutic technologies. Growing investments in VR-based mental health solutions are being seen in nations like China, Japan, India, and South Korea, as well as in telehealth and healthcare infrastructure. Furthermore, the market is expanding due to a sizable patient base, increased stress and anxiety levels, and government programs that encourage innovation in digital health.

Key players in the market

Some of the key players in VR Exposure Therapy Market include Google, Accelerated Care Plus Corporation, Microsoft, ImmersiveTouch Inc, Oculus VR Inc, Atheer, Mindmaze Inc, BehaVR Inc, Limbix Inc., AppliedVR Inc, Samsung Electronics, Virtually Better, Inc., Echopixel Inc, XRHealth Inc, Truevision Inc, Vivid Vision and Oxford VR Inc.

Key Developments:

In February 2025, Microsoft Corp. and Anduril Industries announced an expanded partnership to drive the next phase of the U.S. Army's Integrated Visual Augmentation System (IVAS) program. Through this partnership agreement, and pending Department of Defense approval, Anduril will assume oversight of production, future development of hardware and software, and delivery timelines.

In February 2025, XRHealth and extended reality (XR) solutions, announces that they acquired the immersive, digital therapeutics company RealizedCare, further advancing AI-powered, value-based care in healthcare. With this acquisition, XRHealth solidifies its position as the largest AI-driven therapeutic XR platform worldwide.

In December 2024, Google is teaming up with Samsung to take on Meta and Apple in the resurgent market for smart glasses and virtual-reality headsets, almost a decade after suspending consumer sales of its controversial Google Glass device. Samsung will release the first device based on a new version of Google's Android smartphone operating system that has been customised for headsets and glasses, which the Alphabet-owned internet group described as the next generation of computing.

Components Covered:

  • VR Headset
  • VR Software & Modules
  • VR Workstation
  • VR Earphones
  • VR Position Tracker/ Sensors
  • Biofeedback Monitor
  • Other Components

Therapy Types Covered:

  • Post-Traumatic Stress Disorder (PTSD)
  • Phobias
  • Anxiety Disorders
  • Obsessive-Compulsive Disorder (OCD)
  • Addiction & Substance Abuse
  • Depression & Mood Disorders
  • Other Therapy Types

Technologies Covered:

  • Fully Immersive VR
  • Semi-Immersive VR
  • Non-Immersive VR
  • AI-Enhanced VR
  • Haptic-Integrated VR

Applications Covered:

  • Mental Disorder & Addiction Management
  • Pediatric Anxiety & Phobia Treatment
  • Education & Medical Training
  • Remote Therapy & Telehealth Integration
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Mental Health Centers
  • Academic & Research Institutions
  • Private Therapy Practices
  • Government & Defense Organizations
  • Telehealth Platforms & Digital Therapeutics Providers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global VR Exposure Therapy Market, By Component

  • 5.1 Introduction
  • 5.2 VR Headset
  • 5.3 VR Software & Modules
  • 5.4 VR Workstation
  • 5.5 VR Earphones
  • 5.6 VR Position Tracker/ Sensors
  • 5.7 Biofeedback Monitor
  • 5.8 Other Components

6 Global VR Exposure Therapy Market, By Therapy Type

  • 6.1 Introduction
  • 6.2 Post-Traumatic Stress Disorder (PTSD)
  • 6.3 Phobias
  • 6.4 Anxiety Disorders
  • 6.5 Obsessive-Compulsive Disorder (OCD)
  • 6.6 Addiction & Substance Abuse
  • 6.7 Depression & Mood Disorders
  • 6.8 Other Therapy Types

7 Global VR Exposure Therapy Market, By Technology

  • 7.1 Introduction
  • 7.2 Fully Immersive VR
  • 7.3 Semi-Immersive VR
  • 7.4 Non-Immersive VR
  • 7.5 AI-Enhanced VR
  • 7.6 Haptic-Integrated VR

8 Global VR Exposure Therapy Market, By Application

  • 8.1 Introduction
  • 8.2 Mental Disorder & Addiction Management
  • 8.3 Pediatric Anxiety & Phobia Treatment
  • 8.4 Education & Medical Training
  • 8.5 Remote Therapy & Telehealth Integration
  • 8.6 Other Applications

9 Global VR Exposure Therapy Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Mental Health Centers
  • 9.4 Academic & Research Institutions
  • 9.5 Private Therapy Practices
  • 9.6 Government & Defense Organizations
  • 9.7 Telehealth Platforms & Digital Therapeutics Providers
  • 9.8 Other End Users

10 Global VR Exposure Therapy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Google
  • 12.2 Accelerated Care Plus Corporation
  • 12.3 Microsoft
  • 12.4 ImmersiveTouch Inc
  • 12.5 Oculus VR Inc
  • 12.6 Atheer
  • 12.7 Mindmaze Inc
  • 12.8 BehaVR Inc
  • 12.9 Limbix Inc.
  • 12.10 AppliedVR Inc
  • 12.11 Samsung Electronics
  • 12.12 Virtually Better, Inc.
  • 12.13 Echopixel Inc
  • 12.14 XRHealth Inc
  • 12.15 Truevision Inc
  • 12.16 Vivid Vision
  • 12.17 Oxford VR Inc

List of Tables

  • Table 1 Global VR Exposure Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global VR Exposure Therapy Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global VR Exposure Therapy Market Outlook, By VR Headset (2024-2032) ($MN)
  • Table 4 Global VR Exposure Therapy Market Outlook, By VR Software & Modules (2024-2032) ($MN)
  • Table 5 Global VR Exposure Therapy Market Outlook, By VR Workstation (2024-2032) ($MN)
  • Table 6 Global VR Exposure Therapy Market Outlook, By VR Earphones (2024-2032) ($MN)
  • Table 7 Global VR Exposure Therapy Market Outlook, By VR Position Tracker/ Sensors (2024-2032) ($MN)
  • Table 8 Global VR Exposure Therapy Market Outlook, By Biofeedback Monitor (2024-2032) ($MN)
  • Table 9 Global VR Exposure Therapy Market Outlook, By Other Components (2024-2032) ($MN)
  • Table 10 Global VR Exposure Therapy Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 11 Global VR Exposure Therapy Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2024-2032) ($MN)
  • Table 12 Global VR Exposure Therapy Market Outlook, By Phobias (2024-2032) ($MN)
  • Table 13 Global VR Exposure Therapy Market Outlook, By Anxiety Disorders (2024-2032) ($MN)
  • Table 14 Global VR Exposure Therapy Market Outlook, By Obsessive-Compulsive Disorder (OCD) (2024-2032) ($MN)
  • Table 15 Global VR Exposure Therapy Market Outlook, By Addiction & Substance Abuse (2024-2032) ($MN)
  • Table 16 Global VR Exposure Therapy Market Outlook, By Depression & Mood Disorders (2024-2032) ($MN)
  • Table 17 Global VR Exposure Therapy Market Outlook, By Other Therapy Types (2024-2032) ($MN)
  • Table 18 Global VR Exposure Therapy Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global VR Exposure Therapy Market Outlook, By Fully Immersive VR (2024-2032) ($MN)
  • Table 20 Global VR Exposure Therapy Market Outlook, By Semi-Immersive VR (2024-2032) ($MN)
  • Table 21 Global VR Exposure Therapy Market Outlook, By Non-Immersive VR (2024-2032) ($MN)
  • Table 22 Global VR Exposure Therapy Market Outlook, By AI-Enhanced VR (2024-2032) ($MN)
  • Table 23 Global VR Exposure Therapy Market Outlook, By Haptic-Integrated VR (2024-2032) ($MN)
  • Table 24 Global VR Exposure Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 25 Global VR Exposure Therapy Market Outlook, By Mental Disorder & Addiction Management (2024-2032) ($MN)
  • Table 26 Global VR Exposure Therapy Market Outlook, By Pediatric Anxiety & Phobia Treatment (2024-2032) ($MN)
  • Table 27 Global VR Exposure Therapy Market Outlook, By Education & Medical Training (2024-2032) ($MN)
  • Table 28 Global VR Exposure Therapy Market Outlook, By Remote Therapy & Telehealth Integration (2024-2032) ($MN)
  • Table 29 Global VR Exposure Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 30 Global VR Exposure Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global VR Exposure Therapy Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 32 Global VR Exposure Therapy Market Outlook, By Mental Health Centers (2024-2032) ($MN)
  • Table 33 Global VR Exposure Therapy Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
  • Table 34 Global VR Exposure Therapy Market Outlook, By Private Therapy Practices (2024-2032) ($MN)
  • Table 35 Global VR Exposure Therapy Market Outlook, By Government & Defense Organizations (2024-2032) ($MN)
  • Table 36 Global VR Exposure Therapy Market Outlook, By Telehealth Platforms & Digital Therapeutics Providers (2024-2032) ($MN)
  • Table 37 Global VR Exposure Therapy Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.